References
- Bartges J.W.: Chronic kidney disease in dogs and cats. Vet Clin North Am Small Anim Pract 2012, 42, 669–692, doi: 10.1016/j.cvsm.2012.04.008.
- Bradley M.S., Boudreau M.H., Grenier C., Huang Z., Murphy S.K., Siddiqui N.Y.: Urine RNA Processing in a Clinical Setting: Comparison of Three Protocols. Female Pelvic Med Reconstr Surg 2019, 25, 247–251, doi: 10.1097/SPV.0000000000000525.
- Bragato N., Borges N.C., Fioravanti M.C.S.: B-mode and Doppler ultrasound of chronic kidney disease in dogs and cats. Vet Res Commun 2017, 41, 307–315, doi: 10.1007/s11259-017-9694-9.
- Chagnac A., Zingerman B., Rozen-Zvi B., Herman-Edelstein M.: Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity. Nephron 2019, 143, 38–42, doi: 10.1159/000499486.
- Coady M., Fletcher D.J., Goggs R.: Severity of ionized hypercalcemia and hypocalcemia is associated with etiology in dogs and cats. Front Vet Sci 2019, 6, e276, doi: 10.3389/fvets.2019.00276.
- Crivellenti L.Z., Borin‐Crivellenti S., Fertal K.L., Contin C.M., Miranda C.M., Santana A.E.: Occult gastrointestinal bleeding is a common finding in dogs with chronic kidney disease. Vet Clin Pathol 2017, 46, 132–137, doi: 10.1111/vcp.12461.
- De Medeiros Torres M., Chitarra C.S., Nakazato L., de Almeida A.B.P.F., Sousa V.R.F.: Nephrin gene expression in chronic kidney disease of dogs with Leishmania (Leishmania) infantum chagasi. Braz J Infect Dis 2016, 20, 516–518, doi: 10.1016/j.bjid.2016.07.008.
- Dunaevich A., Chen H., Musseri D., Kuzi S., Mazaki‐Tovi M., Aroch I., Segev G.: Acute on chronic kidney disease in dogs: Etiology, clinical and clinicopathologic findings, prognostic markers, and survival. J Vet Intern Med 2020, 34, 2507–2515, doi: 10.1111/jvim.15931.
- Endlich N., Lange T., Kuhn J., Klemm P., Kotb A.M., Siegerist F., Kindt F., Lindenmeyer M.T., Cohen C.D., Kuss A.W., Nath N., Retting R., Lendeckel U., Zimmermann U., Amann K., Stracke S., Endlich K.: BDNF: mRNA expression in urine cells of patients with chronic kidney disease and its role in kidney function. J Cell Mol Med 2018, 22, 5265–5277, doi: 10.1111/jcmm.13762.
- Fukuda A., Minakawa A., Kikuchi M., Sato Y., Nagatomo M., Nakamura S., Mizoguchi T., Fukunaga N., Shibata H., Naik A.S., Wiggins R.C., Fujimoto S.: Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy. Sci Rep 2020, 10, 1–11, doi: 10.1038/s41598-020-75320-1.
- Green M.R., Sambrook J.: Precipitation of RNA with Ethanol. Cold Spring Harb Protoc 2020, doi: 10.1101/pdb.prot101717.
- Guo Y., Pace J., Li Z., Ma’ayan A., Wang Z., Revelo M.P., Chen E., Gu X., Attalah A., Yang Y., Estrada C., Yang V.W., He J.C., Mallipattu S.K.: Podocyte-specific induction of Krüppel-like factor 15 restores differentiation markers and attenuates kidney injury in proteinuric kidney disease. J Am Soc Nephrol 2018, 29, 2529–2545, doi: 10.1681/ASN.2018030324.
- Helal I., Fick-Brosnahan G.M., Reed-Gitomer B., Schrier R.W.: Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012, 8, 293–300, doi: 10.1038/nrneph.2012.19.
- Ichii O., Yabuki A., Sasaki N., Otsuka S., Ohta H., Yamasaki M., Takiguchi M., Nami Y., Hashimoto Y., Endoh D., Kon Y.: Pathological correlations between podocyte injuries and renal functions in canine and feline chronic kidney diseases. Histol Histopathol 2011, 26, 1243–1255, doi: 10.14670/HH-26.1243.
- International Renal Interest Society: IRIS Staging of CKD (modified 2019). International Renal Interest Society, Cambridge, 2019. http://www.iris-kidney.com/pdf/IRIS_Staging_of_CKD_modified_2019.pdf
- Khan T.M., Khan K.N.M.: Acute kidney injury and chronic kidney disease. Vet Pathol 2015, 52, 441–444, doi: 10.1177/0300985814568358.
- Medyńska A., Chrzanowska J., Kościelska-Kasprzak K., Bartoszek D., Żabińska M., Zwolińska D.: Alpha-1 Acid Glycoprotein and Podocin mRNA as Novel Biomarkers for Early Glomerular Injury in Obese Children. J Clin Med 2021, 10, 4129, doi: 10.3390/jcm10184129.
- Monteiro M.B., Santos-Bezerra D.P., Thieme K., Passarelli M., Machado U.F., Lin C.J., Corrêa-Giannella M.L.: Optimization of total RNA isolation from human urinary sediment. Clin Chim Acta 2016, 462, 158–161, doi: 10.1016/j.cca.2016.09.018.
- Nagata D., Hishida E., Masuda T.: Practical Strategy for Treating Chronic Kidney Disease (CKD)-Associated with Hypertension. Int J Nephrol Renovasc Dis 2020, 13, 171–178, doi: 10.2147/IJNRD.S259931.
- Neal C.R.: Podocytes… What’s under yours? (Podocytes and foot processes and how they change in nephropathy). Front Endocrinol 2015, 6, e9, doi: 10.3389/fendo.2015.00009.
- O’Neill D.G., Elliott J., Church D.B., McGreevy P.D., Thomson P.C., Brodbelt D.C.: Chronic kidney disease in dogs in UK veterinary practices: prevalence, risk factors, and survival. J Vet Int Med 2013, 27, 814–821, doi: 10.1111/jvim.12090.
- O’Neill W.C.: Targeting serum calcium in chronic kidney disease and end-stage renal disease: is normal too high? Kidney Int 2016, 89, 40–45, doi: 10.1016/j.kint.2015.10.001.
- Perondi F., Lippi I., Marchetti V., Bruno B., Borrelli A., Citi S.: How Ultrasound Can Be Useful for Staging Chronic Kidney Disease in Dogs: Ultrasound Findings in 855 Cases. Vet Sci 2020, 7, e147, doi: 10.3390/vetsci7040147.
- Rudinsky A.J., Harjes L.M., Byron J., Chew D.J., Toribio R.E., Langston C., Parker V.J.: Factors associated with survival in dogs with chronic kidney disease. J Vet Int Med 2018, 32, 1977– 1982, doi: 10.1111/jvim.15322.
- Sato Y., Wharram B.L., Lee S.K., Wickman L., Goyal M., Venkatareddy M., Chang J.W., Wiggins J.E., Lienczewski C., Kretzler M., Wiggins R.C.: Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 2009, 20, 1041– 1052, doi: 10.1681/ASN.2007121328.
- Siwińska N., Pasławska U., Bąchor R., Szczepankiewicz B., Żak A., Grocholska P., Szewczuk Z.: Evaluation of podocin in urine in horses using qualitative and quantitative methods. PLOS One 2020, 15, e0240586, doi: 10.1371/journal.pone.0240586.
- Szczepankiewicz B., Bąchor R., Pasławski R., Siwińska N., Pasławska U., Konieczny A., Szewczuk Z.: Evaluation of tryptic podocin peptide in urine sediment using LC-MS-MRM method as a potential biomarker of glomerular injury in dogs with clinical signs of renal and cardiac disorders. Molecules 2019, 24, e3088, doi: 10.3390/molecules24173088.
- Szczepankiewicz B., Pasławska U., Pasławski R., Gębarowski T., Zasada W., Michałek M., Noszczyk-Nowak A.: The urine podocin/creatinine ratio as a novel biomarker of cardiorenal syndrome in dogs due to degenerative mitral valve disease. J Physiol Pharmacol 2019, 70, 2, 229–238, doi: 10.26402/jpp.2019.2.06.
- Trimarchi H.: Podocyturia: What is in a name? J Transl Intern Med 2015, 3, 51–56, doi: 10.1515/jtim-2015-0003.
- Untergasser A., Nijveen H., Rao X., Bisseling T., Geurts R., Leunissen J.A.M.: Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res 2007, 35, W71–W74, doi: 10.1093/nar/gkm306.
- Vogelmann S.U., Nelson W.J., Myers B.D., Lemley K.V.: Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 2003, 285, F40–F48, doi: 10.1152/ajprenal.00404.2002.
- Watson A.D.J., Lefebvre H.P., Elliott J.: Using urine specific gravity (revised 2015). International Renal Interest Society, Cambridge, 2015. http://www.iris-kidney.com/education/urine_specific_gravity.html
- Wickman L., Afshinnia F., Wang S.Q., Yang Y., Wang F., Chowdhury M., Graham D., Hawkins J., Nishizono R., Tanzer M., Wiggins J.E., Escobar G.A., Rovin B., Song P., Gipson D., Kershaw D., Wiggins R.C.: Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J Am Soc Nephrol 2013, 24, 2081–2095, doi: 10.1681/ASN.2013020173.